Inspire projected an increase of about 26% in its full-year revenue for 2024, landing somewhere between $783 million and $793 million. Inspire Medical Systems FDA Class I recall sleep apnea ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...

Maple Grove's Inspire Medical Systems uses an electric stimulator similar to a pacemaker to treat sleep apnea, snoring. By Joe Carlson November 19, 2016 at 7:21PM ...

According to an FDA Roundup news release, the Inspire II Upper Airway Stimulator system (Inspire Medical Systems Inc.), a device placed inside a patient’s body, is now approved for patients with ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...

Inspire Medical Systems recalls Model 3028 IPG due to manufacturing defect causing serious health risks. Learn about the FDA Class I recall implications and patient advisories.

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...